Medicina
Departamento
University of Pecs
Pécs, HungríaPublicaciones en colaboración con investigadores/as de University of Pecs (46)
2024
-
Genomic and Immunologic Correlates in Prostate Cancer with High Expression of KLK2
International Journal of Molecular Sciences, Vol. 25, Núm. 4
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and Research
Chest, Vol. 163, Núm. 3, pp. 586-598
-
Comparison of the Accuracy of the 7-Item HADS Depression Subscale and 14-Item Total HADS for Screening for Major Depression: A Systematic Review and Individual Participant Data Meta-Analysis
Psychological Assessment, Vol. 35, Núm. 2, pp. 94-114
2022
-
Development and validation of a patient-reported outcome measure for systemic sclerosis: the EULAR Systemic Sclerosis Impact of Disease (ScleroID) questionnaire
Annals of the rheumatic diseases, Vol. 81, Núm. 4, pp. 507-515
-
Ethical and medical dilemmas in paid living kidney donor transplantation
Transplantation Reviews, Vol. 36, Núm. 4
-
International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis
JAMA Dermatology, Vol. 158, Núm. 5, pp. 561-572
2020
-
Health Assessment Questionnaire-Disability Index (HAQ-DI) use in modelling disease progression in diffuse cutaneous systemic sclerosis: an analysis from the EUSTAR database
Arthritis research & therapy, Vol. 22, Núm. 1, pp. 257
-
New genotype-phenotype correlations in a large European cohort of patients with sarcoglycanopathy
Brain, Vol. 143, Núm. 9, pp. 2696-2708
-
Outcomes of limited cutaneous systemic sclerosis patients: Results on more than 12,000 patients from the EUSTAR database
Autoimmunity Reviews, Vol. 19, Núm. 2
-
Racial differences in systemic sclerosis disease presentation: A European Scleroderma Trials and Research group study
Rheumatology (United Kingdom), Vol. 59, Núm. 7, pp. 1684-1694
2019
-
Differences associated with age at onset in early systemic sclerosis patients: a report from the EULAR Scleroderma Trials and Research Group (EUSTAR) database
Scandinavian Journal of Rheumatology, Vol. 48, Núm. 1, pp. 42-51
-
Hot topics on procalcitonin use in clinical practice, can it help antibiotic stewardship?
International Journal of Antimicrobial Agents
-
Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: A European Scleroderma Trials and Research (EUSTAR) analysis
Annals of the Rheumatic Diseases, Vol. 78, Núm. 9, pp. 1242-1248
-
Procalcitonin (PCT)-guided antibiotic stewardship: An international experts consensus on optimized clinical use
Clinical Chemistry and Laboratory Medicine, Vol. 57, Núm. 9, pp. 1308-1318
-
Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the european scleroderma trials and research (eustar) cohort
Annals of the Rheumatic Diseases, Vol. 78, Núm. 5, pp. 648-656
2018
-
Brief Report: Smoking in Systemic Sclerosis: A Longitudinal European Scleroderma Trials and Research Group Study
Arthritis and Rheumatology, Vol. 70, Núm. 11, pp. 1829-1834
-
Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: The European Scleroderma Observational Study
Rheumatology (United Kingdom), Vol. 57, Núm. 2, pp. 370-381
-
Gender differences in early systemic sclerosis patients: A report from the EULAR scleroderma trials and research group (EUSTAR) database
Clinical and Experimental Rheumatology, Vol. 36, pp. S68-S75
-
Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study
Annals of the Rheumatic Diseases, Vol. 77, Núm. 4, pp. 563-570